# Transcript — Interview-first — clarifying questions before research starts / 访谈优先——研究开始前先提出澄清问题

- Scenario: `agent-interview-en` (kind: agent, lang: en)
- Outcome: **PASS**
- Session: 2026-09-06T05:33:39.476Z → 2026-09-06T05:34:02.356Z
- Replay: `node demos/run-demo.mjs --only agent-interview-en --publish` (spends LLM tokens; manual-run only)

## Prompt / 提示词

```text
Using the bioresearcher-deep-research skill, run a deep research report on CAR-T therapy safety in solid tumors.
```

## Tool calls (1) / 工具调用

### 1. `skill` — completed

Input:
```json
{"name":"bioresearcher-deep-research"}
```
Output (trimmed):
```text
<skill_content name="bioresearcher-deep-research">
# Skill: bioresearcher-deep-research

# Bioresearcher Deep Research

Reference-based biomedical research: interview the user, split the topic into
research aspects, investigate each aspect with biomcp tools, then synthesize a
succinct, accurately cited report. Harness-agnostic: works with or without a
subagent/Task tool.

## What it does

- Decomposes a biomedical question (disease, drug, gene, variant, trial
  landscape, patent space, dataset) into 2-5 independent research aspects.
- Runs one focused worker per aspect - in parallel via the harness's
… [trimmed 325 more line(s)]
```

## Final answer (verbatim) / 最终回答（原文）

Before starting the deep research run, I need to clarify the scope (Step 1 of the workflow). Please answer the following — one round, then I'll proceed:

1. **Safety outcomes**: Which toxicities matter most — CRS/ICANS only, on-target/off-tumor toxicity, or the full safety spectrum (including neurotoxicity, hematologic toxicity, insertional oncogenesis concerns)?
2. **Tumor scope**: Pan-solid-tumor overview, or specific indications (e.g., glioblastoma, pancreatic, ovarian, lung)? Should hematologic malignancy data be included as a comparator?
3. **Time window**: Last 5 years, or all available evidence?
4. **Evidence scope**: Clinical trials only, or also include reviews/meta-analyses, case reports, and regulatory (FDA) documents?
5. **Output format**: Default is a full report with numbered citations as Markdown + rendered HTML under `reports/` — is that fine, or Markdown-only (`no-html`)?

I'll wait for your reply before decomposing the topic and launching the research.
